Assessing the Efficacy of Telemedicine for Managing Chronic Illnesses in Younger Adults with Type 2 Diabetes
DOI:
https://doi.org/10.56294/mw2023138Keywords:
Telemedicine, Chronic Illnesses, Younger Adults, Type 2 Diabetes, ANOVAAbstract
Telemedicine is transforming chronic disease management, particularly for younger adults with Type 2 Diabetes. This investigation evaluates its efficacy in improving glycemic control, adherence, and lifestyle changes compared to traditional care. To assess the effectiveness of telemedicine for managing Type 2 Diabetes in younger adults by evaluating health outcomes, patient engagement, and satisfaction. Data from 200 participants' intervention and control is collected at four periods (Baseline, 3, 6, and 12 months); data collection can be conducted via surveys. Key variables include HbA1c levels, medication adherence, patient engagement score, lifestyle changes score, and satisfaction with care. These variables assess the impact of telemedicine on diabetes management compared to standard in-person healthcare approaches. Using IBM SPSS 26, paired t-tests analyze intra-group HbA1c changes, ANOVA compares multi-period variations, and logistic regression determines adherence predictors. Preliminary findings suggested that telemedicine improves HbA1c levels, engagement, and adherence, though lifestyle changes vary significantly across participants. Telemedicine effectively improved diabetes management outcomes, showing significant gains in HbA1c reduction (88%), medication adherence (85%), and patient engagement (82%). Findings support telemedicine as a viable alternative to in-person care, though further analyses should explore long-term impacts and scalability challenges.
References
[1] Fazio S, Edwards J, Miyamoto S, Henderson S, Dharmar M, Young HM. More than A1C: Types of success among adults with type-2 diabetes participating in a technology-enabled nurse coaching intervention. Patient education and counseling. 2019 Jan 1;102(1):106-12. https://doi.org/10.1016/j.pec.2018.08.028
[2] Romero-Aroca P, Valls A, Moreno A, Sagarra-Alamo R, Basora-Gallisa J, Saleh E, Baget-Bernaldiz M, Puig D. A clinical decision support system for diabetic retinopathy screening: creating a clinical support application. Telemedicine and e-Health. 2019 Jan 1;25(1):31-40. https://doi.org/10.1089/tmj.2017.0282
[3] Fisher L, Polonsky W, Asuni A, Jolly Y, Hessler D. The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study. Journal of Diabetes and its Complications. 2020 Dec 1;34(12):107748. https://doi.org/10.1016/j.jdiacomp.2020.107748
[4] Leblalta B, Kebaili H, Lee S. PDB1 telemedicine use for gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Value in Health Regional Issues. 2020 Sep 1;22:S32. https://doi.org/10.1016/j.vhri.2020.07.160
[5] McGloin H, O'Connell D, Glacken M, Mc Sharry P, Healy D, Winters-O'Donnell L, Crerand K, Gavaghan A, Doherty L. Patient empowerment using electronic telemonitoring with telephone support in the transition to insulin therapy in adults with type 2 diabetes: observational, pre-post, mixed methods study. Journal of medical Internet research. 2020 May 14;22(5):e16161. https://doi.org/10.2196/16161
[6] Young HM, Miyamoto S, Dharmar M, Tang-Feldman Y. Nurse coaching and mobile health compared with usual care to improve diabetes self-efficacy for persons with type 2 diabetes: randomized controlled trial. JMIR mHealth and uHealth. 2020 Mar 2;8(3):e16665. https://doi.org/10.2196/16665
[7] Reid MW, Krishnan S, Berget C, Cain C, Thomas JF, Klingensmith GJ, Raymond JK. CoYoT1 clinic: home telemedicine increases young adult engagement in diabetes care. Diabetes technology & therapeutics. 2018 May 1;20(5):370-9. https://doi.org/10.1089/dia.2017.0450
[8] Yan M, Or C. Factors in the 4-week acceptance of a computer-based, chronic disease self-monitoring system in patients with type 2 diabetes mellitus and/or hypertension. Telemedicine and e-Health. 2018 Feb 1;24(2):121-9.https://doi.org/10.1089/tmj.2017.0064
[9] Albanese-O'Neill A, Beauchamp G, Thomas N, Westen SC, Johnson N, Schatz D, Haller MJ. Transition education for young adults with type 1 diabetes: pilot feasibility study for a group telehealth intervention. Jmir Diabetes. 2018 Nov 5;3(4):e10909. https://doi.org/10.2196/10909
[10] Liese AD, Ma X, Reid L, Sutherland MW, Bell BA, Eberth JM, Probst JC, Turley CB, Mayer‐Davis EJ. Health care access and glycemic control in youth and young adults with type 1 and type 2 diabetes in South Carolina. Pediatric diabetes. 2019 May;20(3):321-9. https://doi.org/10.1111/pedi.12822
[11] Sacre JW, Holmes‐Truscott E, Salim A, Anstey KJ, Drummond GR, Huxley RR, Magliano DJ, van Wijngaarden P, Zimmet PZ, Speight J, Shaw JE. Impact of the COVID‐19 pandemic and lockdown restrictions on psychosocial and behavioral outcomes among Australian adults with type 2 diabetes: findings from the PREDICT cohort study. Diabetic Medicine. 2021 Sep;38(9):e14611. https://doi.org/10.1111/dme.14611.
Published
Issue
Section
License
Copyright (c) 2023 Swayamsidha Mangaraj , H. Malathi , Shilpi Singh (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
